CryoXtract Named an Industry Partner of the Integrated BioBank of Luxembourg
News Jun 12, 2014
CryoXtract is working with Integrated BioBank of Luxembourg (IBBL) to develop an efficient and effective workflow for the processing and preparation of fecal samples for analysis and distribution. As part of this effort the IBBL purchased CryoXtract’s CXT350 system a benchtop solution that utilizes a proprietary frozen coring technology to facilitate the access and re-access of high-value biosamples resulting in optimized scientific outcomes.
The IBBL is the fourth European group this year to purchase a CryoXtract system. Researchers from France’s National Institute for Agricultural Research (INRA) Vrije Universiteit Brussel (VUB) and others have also implemented CryoXtract’s CXT750 system into their workflow to assist in the study of the human gut microbiome – a rapidly evolving area of scientific research that lies at the nexus of the food pharmaceutical and even animal health industries. CryoXtract’s CXT350 and fully automated CXT750 systems both offer a platform for the handling and distribution of biologically sensitive biosamples allowing scientists to exercise best practices in their use.
“CryoXtract’s pioneering efforts working in close coordination with industry leaders have served a critical role in addressing important applications for this fast-growing area of scientific development” said John McCarthy Chief Executive Officer of CryoXtract. “The integration of our systems into the operational workflows of industry leaders like the IBBL and INRA are representative of the convergence of major industries on the study of the microbiome and their accelerated need for effective biobanking solutions.”
INRA purchased two CXT750s to perform a key reformatting process within their newly established Gut Microbiome sample workflow. These systems which have been installed at INRA’s new lab facility in Jouy-en-Josas Cedex France are helping researchers maintain fecal samples in a frozen state at -80°C eliminate freeze-thaw cycling and preserve the in vivo profile of the microbiome. The process also preserves the integrity of the original parent sample for future use streamlines sample processing and increases lab efficiency through the automated hands-free operation of sample tube management sample coring frozen aliquot dispensing and reusable coring probe cleaning.
“Our systems are allowing labs to drive forward the standardization of a viable workflow which will allow for more research and discovery in the human gut microbiome” said Larry Chin Vice President of Business Development for CryoXtract. “Standardization is the key to utilization particularly in the case of fecal samples which traditionally have been stored in a variety of formats impacting their accessibility to researchers.”
CryoXtract presented a poster entitled “Overcoming the Challenges of Fecal Sample Handling” at this year’s ISBER Annual Meeting a copy of which can be seen in the Resources section of the company’s website www.cryoxtract.com. The company will be presenting a second poster on standardized fecal sample aliquotting at the Rowett-INRA 2014 Gut Microbiology: From Sequence to Function conference in Aberdeen Scotland later this month.
2nd International Conference on Pharmaceutical Research & Innovations in Pharma Industry
May 30 - May 31, 2019